Download PDF
Thromb Haemost 2008; 100(03): 391-396
DOI: 10.1160/TH08-04-0213
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II

Maria Atta
1   Endocrinology and Metabolic Medicine, Imperial College London, London, UK
,
David Crook
2   Clinical Investigations and Research Unit, Royal Sussex County Hospital, Sussex, UK
,
Faria Shafique
1   Endocrinology and Metabolic Medicine, Imperial College London, London, UK
,
Desmond G. Johnston
1   Endocrinology and Metabolic Medicine, Imperial College London, London, UK
,
Ian F. Godsland
1   Endocrinology and Metabolic Medicine, Imperial College London, London, UK
› Author Affiliations
Further Information

Publication History

Received 05 April 2008

Accepted after minor revision 09 July 2008

Publication Date:
22 November 2017 (online)

    Permissions and Reprints

Summary

The pro- and antiatherogenic roles of apolipoproteins B andA-I, respectively, are well-established although the importance of apolipoprotein A-II remains unclear. There is extensive evidence for the involvement of plasma lipoproteins in haemostatic function. However, in-vivo studies of relationships between haemostatic variables and apolipoprotein concentrations are very limited. Plasma fibrinogen, factors VIIc and Xc (FVIIc and FXc, respectively), apolipoproteins (apo) A-I, A-II and B, triglycerides, total, low-density and high-density lipoprotein (HDL) cholesterol, and cholesterol in HDL subfractions 2 and 3 were measured in 186 apparently healthy Caucasian men (aged 26–78 years; body mass index 19.9–37.8 kg/m2).Associations between haemostatic, apolipoprotein,lipid and lipoprotein variables were explored in uni- and multivariable analyses. Fibrinogen did not correlate with any of the lipid-related variables. FVIIc and FXc were significant positive univariate correlates of total cholesterol (correlation coefficients 0.26,p<0.001 and 0.19,p<0.05,respectively) triglycerides (0.37, p<0.001 and 0.36, p<0.001), and apoB (0.21, p<0.01 and 0.17, p<0.05) and apoA-II (0.19, p<0.05 and 0.29, p<0.001). HDL2 subfraction cholesterol correlated negatively with FVIIc and FXc (-0.20, p<0.01 and –0.22, p<0.01, respectively). In multivariable analysis, only the associations of FVIIc and FXc with total cholesterol, triglycerides and apoA-II remained statistically significant. In conclusion, total cholesterol and triglycerides were the major independent lipid correlates of FVIIc and FXc. The independent and positive associations of apoA-II with FVIIc and FXc suggest a prothrombotic involvement for this apolipoprotein

Keywords

Apolipoproteins - high density lipoprotein - lipids - apoA-II - factor VII - factor X - fibrinogen
 

  • References

  • 1 Alessi M-C, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008; 99: 995-1000.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Rosenson RS, Lowe GD. Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis 1998; 140: 271-280.
    CrossrefPubMedGoogle Scholar
  • 3 Rota S. et al. Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E. Blood 1998; 91: 508-515.
    PubMedGoogle Scholar
  • 4 Griffin JH. et al. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 1999; 103: 219-227.
    CrossrefPubMedGoogle Scholar
  • 5 Nofer JR. et al. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002; 161: 1-16.
    CrossrefPubMedGoogle Scholar
  • 6 Carson SD. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VII and tissue factor. FEBS Lett 1981; 132: 37-40.
    CrossrefPubMedGoogle Scholar
  • 7 Lesnik P. et al. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is prudentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb Vasc Biol 1993; 13: 1066-1075.
    CrossrefPubMedGoogle Scholar
  • 8 Schultz JR. et al. Protein composition determines the antiatherogenic properties of HDL in transgenic mice. Nature 1993; 365: 762-764.
    CrossrefPubMedGoogle Scholar
  • 9 Walldius G. et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026-2033.
    CrossrefPubMedGoogle Scholar
  • 10 Blanco-Vaca F. et al. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res 2001; 42: 1727-1739.
    PubMedGoogle Scholar
  • 11 Tailleux A. et al. Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 2002; 164: 1-13.
    CrossrefPubMedGoogle Scholar
  • 12 Carson SD. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II. J Biol Chem 1987; 262: 718-721.
    PubMedGoogle Scholar
  • 13 Epand RM. et al. HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. Arterioscler Thromb 1994; 14: 1775-1783.
    CrossrefPubMedGoogle Scholar
  • 14 Ettelaie C. et al. Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation. Arterioscler Thromb Vasc Biol 1999; 19: 1784-1790.
    CrossrefPubMedGoogle Scholar
  • 15 Godsland IF. et al. Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). J Intern Med 1998; 244: 33-41.
    CrossrefPubMedGoogle Scholar
  • 16 Godsland IF. et al. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001; 86: 719-723.
    PubMedGoogle Scholar
  • 17 Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978; 19: 65-76.
    PubMedGoogle Scholar
  • 18 Gidez LI. et al. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982; 23: 1206-1223.
    PubMedGoogle Scholar
  • 19 Kalaria VG. et al. Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol 2000; 85: 1401-1408.
    CrossrefPubMedGoogle Scholar
  • 20 Brunner EJ. et al. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis 1993; 102: 195-207.
    CrossrefPubMedGoogle Scholar
  • 21 Cooper JA. et al. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation 2000; 102: 2816-2822.
    CrossrefPubMedGoogle Scholar
  • 22 Hansen JB. et al. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men. Thromb Res 2001; 102: 3-13.
    CrossrefPubMedGoogle Scholar
  • 23 Ribas V. et al. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ Res 2004; 95: 789-797.
    CrossrefPubMedGoogle Scholar
  • 24 Castellani LW. et al. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. J Clin Invest 1997; 100: 464-474.
    CrossrefPubMedGoogle Scholar
  • 25 Mackness MI. et al. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-135.
    CrossrefPubMedGoogle Scholar
  • 26 Lesnik P. et al. Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation. Arterioscler Thromb Vasc Biol 1995; 15: 1121-1130.
    CrossrefPubMedGoogle Scholar
  • 27 Godsland IF. et al. Hemostatic risk factors and insulin sensitivity, regional body fat distribution and the metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 190-197.
    CrossrefPubMedGoogle Scholar
  • 28 Castellani LW. et al. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 2001; 50: 643-651.
    CrossrefPubMedGoogle Scholar
  • 29 Weng W, Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci USA 1996; 93: 14788-14794.
    CrossrefPubMedGoogle Scholar
  • 30 Escolà-Gil JC. et al. Overexpression of human apolipoprotein A-II in transgenic mice does not increase their susceptibility to insulin resistance and obesity. Diabetologia 2002; 45: 600-601.
    CrossrefPubMedGoogle Scholar
  • 31 Martín-Campos JM. et al. Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility. Curr Opin Lipidol 2004; 15: 247-253.
    CrossrefPubMedGoogle Scholar
  • 32 Sauvaget D. et al. In vitro transcriptional induction of the human apolipoproteinA-II gene by glucose. Diabetes 2004; 53: 672-678.
    CrossrefPubMedGoogle Scholar
  • 33 Boucher J. et al. Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J Lipid Res 2004; 45: 849-858.
    CrossrefPubMedGoogle Scholar
  • 34 Boisfer E. et al. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis. J Biol Chem 1999; 274: 11564-11572.
    CrossrefPubMedGoogle Scholar
  • 35 Constantino M. et al. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels. Thromb Haemost 1977; 31: 465-474.
    PubMedGoogle Scholar
  • 36 Kjalke M. et al. Plasma lipoproteins enhance tissue factor-independent factor VII activation. Arterioscler Thromb Vasc Biol 2000; 20: 1835-1841.
    CrossrefPubMedGoogle Scholar
  • 37 Silveira A. et al. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol 1996; 16: 1333-1339.
    CrossrefPubMedGoogle Scholar
  • 38 van ’t Hooft FM. et al. Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 2001; 104: 1223-1228.
    CrossrefPubMedGoogle Scholar
  • 39 Delgado-Lista J. et al. An apolipoprotein A-II polymorphism (-265T/C, rs5082) regulates postprandial response to a saturated fat overload in healthy men. J Nutr 2007; 137: 2024-2028.
    CrossrefPubMedGoogle Scholar
  • 40 Saigo M. et al. Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction. Thromb Res 2000; 100: 9-17.
    CrossrefPubMedGoogle Scholar
  • 41 Wielders SJ. et al. Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins. Thromb Haemost 2007; 98: 1056-1062.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Kalopissis AD. et al. Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance. Curr Opin Lipidol 2003; 14: 165-172.
    CrossrefPubMedGoogle Scholar
  • 43 Chinetti G. et al. PPA R-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature Med 2001; 07: 53-58.
    CrossrefPubMedGoogle Scholar
  • 44 Vu-Dac N. et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest 1995; 96: 741-750.
    CrossrefPubMedGoogle Scholar
  • 45 Eggerman TL. et al. Differential tissue-specific expression of human apoA-I and apoA-II. J Lipid Res 1991; 32: 821-828.
    PubMedGoogle Scholar
  • 46 Perlemuter G. et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FA SEB J 2002; 16: 185-194.
    PubMedGoogle Scholar
  • 47 Petit JM. et al. Apolipoprotein-AII Concentrations are Associated With Liver Steatosis in Patients With Chronic Hepatitis C Dig Dis Sci. 2007; 52: 3431-3434.
    PubMedGoogle Scholar
  • 48 Rodríguez-Iñigo E. et al. Expression of factor VII in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis. Blood Coagul Fibrinolysis 2001; 12: 193-199.
    CrossrefPubMedGoogle Scholar
  • 49 Humphries SE. et al. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198.
    CrossrefPubMedGoogle Scholar
  • 50 Constantino M. et al. Increased activity of vitamin K dependent clotting factors in human hyperlipoproteinaemia. Association with cholesterol and triglyceride levels. Thromb Haemost 1977; 38: 465-474.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 51 Simpson HCR. et al. Hypertriglyceridaemia and hypercoagulability. Lancet 1983; i: 786-789.
    PubMedGoogle Scholar
  • 52 Xu N. et al. Association of vitamin K-dependent coagulation proteins and C4b binding protein with trig lyceride-rich lipoproteins of human plasma. Arterioscler Thromb Vasc Biol 1998; 18: 33-39.
    CrossrefPubMedGoogle Scholar
  • 53 Hoffman CJ. et al. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994; 14: 1737-1740.
    CrossrefPubMedGoogle Scholar
  • 54 Lee AJ. et al. Plasma fibrinogen and coronary risk factors: the Scottish Heart and Health Study. J Clin Epidemiol 1990; 43: 913-919.
    CrossrefPubMedGoogle Scholar
  • 55 Koenig W. et al. Association between rheology and components of lipoproteins in human blood: results from the MONICA-Project Augsburg. Circulation 1992; 85: 2197-2204.
    CrossrefPubMedGoogle Scholar
  • 56 Cremer P. et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994; 24: 444-453.
    CrossrefPubMedGoogle Scholar